A Multicenter Single-Arm Objective Performance Criteria Trial to Determine the Efficacy and Safety of High-Frequency Irreversible Electroporation as Primary Treatment for Localized Prostate Cancer: A Study Protocol

Bi-Ming He, Wei Xue, Wei-Gang Yan, Lei Yin, Bai-Jun Dong, Zhi-En Zhou, Heng-Zhi Lin, Yi Zhou, Yan-Qing Wang, Zhen-Kai Shi, Hai Zhou, Shuai-Dong Wang, Shan-Cheng Ren, Xu Gao, Lin-hui Wang, Chuan-Liang Xu, Hai-Feng Wang

Open source

DOI: 10.3389/fonc.2021.760003
Published: 2021-11-10
Container: Frontiers in Oncology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2021.760003,
  title = {A Multicenter Single-Arm Objective Performance Criteria Trial to Determine the Efficacy and Safety of High-Frequency Irreversible Electroporation as Primary Treatment for Localized Prostate Cancer: A Study Protocol},
  author = {Bi-Ming He and Wei Xue and Wei-Gang Yan and Lei Yin and Bai-Jun Dong and Zhi-En Zhou and Heng-Zhi Lin and Yi Zhou and Yan-Qing Wang and Zhen-Kai Shi and Hai Zhou and Shuai-Dong Wang and Shan-Cheng Ren and Xu Gao and Lin-hui Wang and Chuan-Liang Xu and Hai-Feng Wang},
  year = {2021},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2021.760003},
  url = {https://doi.org/10.3389/fonc.2021.760003}
}

RIS

TY  - JOUR
TI  - A Multicenter Single-Arm Objective Performance Criteria Trial to Determine the Efficacy and Safety of High-Frequency Irreversible Electroporation as Primary Treatment for Localized Prostate Cancer: A Study Protocol
AU  - Bi-Ming He
AU  - Wei Xue
AU  - Wei-Gang Yan
AU  - Lei Yin
AU  - Bai-Jun Dong
AU  - Zhi-En Zhou
AU  - Heng-Zhi Lin
AU  - Yi Zhou
AU  - Yan-Qing Wang
AU  - Zhen-Kai Shi
AU  - Hai Zhou
AU  - Shuai-Dong Wang
AU  - Shan-Cheng Ren
AU  - Xu Gao
AU  - Lin-hui Wang
AU  - Chuan-Liang Xu
AU  - Hai-Feng Wang
PY  - 2021
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2021.760003
UR  - https://doi.org/10.3389/fonc.2021.760003
ER  -

APA

He, B., Xue, W., Yan, W., Yin, L., Dong, B., Zhou, Z., Lin, H., Zhou, Y., Wang, Y., Shi, Z., Zhou, H., Wang, S., Ren, S., Gao, X., Wang, L., Xu, C., & Wang, H. (2021). A Multicenter Single-Arm Objective Performance Criteria Trial to Determine the Efficacy and Safety of High-Frequency Irreversible Electroporation as Primary Treatment for Localized Prostate Cancer: A Study Protocol. Frontiers in Oncology. https://doi.org/10.3389/fonc.2021.760003

Source records

crossref · retrieved 2026-09-25T14:54:29.180Z